GSK replaces China chief amid corruption scandal

LONDON (Reuters) – GlaxoSmithKline has appointed one of its top European executives as the new head of operations in China, amid a corruption scandal there that has rocked Britain’s biggest drug maker.

Powered by WPeMatico

This entry was posted in World News. Bookmark the permalink.

Comments are closed.